Emerald Advisers’s GoodRx Holdings GDRX Stock Holding History

Emerald Advisers’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-305	Closed	-$1.52K	–	262
2025 Q2	$1.52K	Hold	305	–	–	﹤0.01%	246
2025 Q1	$1.34K	Hold	305	–	–	﹤0.01%	242
2024 Q4	$1.42K	Hold	305	–	–	﹤0.01%	253
2024 Q3	$2.12K	Sell	305 -5	-2%	-$39	﹤0.01%	247
2024 Q2	$2.42K	Hold	310	–	–	﹤0.01%	246
2024 Q1	$2.2K	Hold	310	–	–	﹤0.01%	242
2023 Q4	$2.08K	Hold	310	–	–	﹤0.01%	239
2023 Q3	$1.75K	Buy	+310	New	+$2.07K	﹤0.01%	230
2023 Q1	–	Sell	-310	Closed	-$1.45K	–	234
2022 Q4	$1.45K	Hold	310	–	–	﹤0.01%	240
2022 Q3	$1K	Hold	310	–	–	﹤0.01%	244
2022 Q2	$2K	Hold	310	–	–	﹤0.01%	245
2022 Q1	$6K	Hold	310	–	–	﹤0.01%	256
2021 Q4	$10K	Buy	+310	New	+$12.5K	﹤0.01%	274
2021 Q3	–	Sell	-484	Closed	-$17K	–	260
2021 Q2	$17K	Buy	+484	New	+$17.9K	﹤0.01%	278
2021 Q1	–	Sell	-484	Closed	-$20K	–	271
2020 Q4	$20K	Sell	484 -1,766	-78%	-$81.1K	﹤0.01%	279
2020 Q3	$125K	Buy	+2,250	New	+$119K	0.01%	236

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Emerald Advisers's GDRX Position: Q3 2025 in Review

Emerald Advisers sold out of GoodRx Holdings (GDRX) in Q3 2025, closing a stake of 305 shares — an estimated $1.52K sold.

Emerald Advisers first reported a position in GDRX in Q3 2020 and held it in 16 quarters. The position peaked at $125K in Q3 2020. 161 funds tracked by Wall St. Rank hold GDRX as of Q3 2025.

Emerald Advisers reported no remaining GoodRx Holdings position as of Q3 2025 after selling out during the quarter.
Emerald Advisers sold 305 GoodRx Holdings shares in Q3 2025, an estimated $1.52K.
Emerald Advisers first reported a position in GoodRx Holdings in Q3 2020 and held it in 16 quarters.
Emerald Advisers's GoodRx Holdings position peaked at $125K in Q3 2020.
161 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2025.

Based on Emerald Advisers's 13F filing for Q3 2025, filed 30 Oct 2025.